| |
|
|
|
|
| |
 |
imaGenes GmbH Joins Roche NimbleGen’s Certified Service Provider Program |
 |
|
Certified Service Provider Program for CGH, ChIP-chip, and DNA Methylation Analysis |
|
|
|
|
|
| |
 |
Aureus Pharma Licenses DDI Predict 2009 Edition to sanofi-aventis |
 |
|
Sanofi-aventis extends its collaboration with Aureus Pharma on the Risks Assessment of Drug-Drug Interactions Involving Multiple Enzymatic Metabolic Pathways |
|
|
|
|
|
| |
 |
MorphoSys and Galapagos Expand Antibody Alliance |
 |
|
They have expanded their antibody alliance in bone and joint diseases |
|
|
|
|
|
| |
 |
Provepharm announces acceptance of Proveblue(R) injectable drug MAA |
 |
|
Acceptance for review under EMEA centralized procedure and validation by Novasep of API cGMP process |
|
|
|
|
|
| |
 |
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP manufacturing agree |
 |
|
For the manufacturing of the active pharmaceutical ingredient (API) for Vitae's lead product candidate, VTP-27999 |
|
|
|
|
|
| |
 |
FDA Grants Emergency Use Authorization to Roche´s Assay for 2009 H1N1 |
 |
|
The Roche kit detects RNA from the 2009 H1N1 influenza A virus allowing rapid and accurate identification of patients infected |
|
|
|
|
|
| |
 |
Innovative competence network for modern pharma packaging |
 |
|
Gerresheimer presents glass and plastic as a synergy bundle |
|
|
|
|
|
| |
 |
Novozymes and Prometic enter into alliance |
 |
|
Regarding proprietary albumin purification technology based upon a synthetic-ligand affinity adsorbent developed by ProMetic’s UK subsidiary, ProMetic BioSciences Ltd |
|
|
|
|
|
| |
 |
Novartis achieves record results in 2009 |
 |
|
Novartis completes CEO succession process with appointment of Joe Jimenez as new CEO and simplified leadership organization |
|
|
|
|
|
| |
 |
454 Sequencing System used to Complete Draft Genome Sequence for Cassava |
 |
|
A $1.3 Million grant from Bill & Melinda Gates Foundation will fund the next phase of research |
|
|
|
|
|
| |
 |
Syringes, pen systems and inhalers:Gerresheimer |
 |
|
Innovation starts with the production technologies: with PharmaPlus™ a previously unattained quality category for glass products has been created |
|
|
|
|
|
| |
 |
Alizé Pharma signs research collaboration & license option agree |
 |
|
Companies to collaborate on an exclusive basis on Alizé Pharma's unacylated ghrelin (AZP-01) program |
|
|
|
|
< Anterior 1 2 3 |
|